405 related articles for article (PubMed ID: 20217053)
1. The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice.
Chen HH; Stoker A; Markou A
Psychopharmacology (Berl); 2010 May; 209(4):343-50. PubMed ID: 20217053
[TBL] [Abstract][Full Text] [Related]
2. Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation.
Gray L; van den Buuse M; Scarr E; Dean B; Hannan AJ
Int J Neuropsychopharmacol; 2009 Feb; 12(1):45-60. PubMed ID: 18593507
[TBL] [Abstract][Full Text] [Related]
3. Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice.
Brody SA; Conquet F; Geyer MA
Psychopharmacology (Berl); 2004 Mar; 172(2):187-95. PubMed ID: 14615875
[TBL] [Abstract][Full Text] [Related]
4. The ampakine CX546 restores the prepulse inhibition and latent inhibition deficits in mGluR5-deficient mice.
Lipina T; Weiss K; Roder J
Neuropsychopharmacology; 2007 Apr; 32(4):745-56. PubMed ID: 16936708
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents.
Kinney GG; Burno M; Campbell UC; Hernandez LM; Rodriguez D; Bristow LJ; Conn PJ
J Pharmacol Exp Ther; 2003 Jul; 306(1):116-23. PubMed ID: 12660307
[TBL] [Abstract][Full Text] [Related]
6. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E
Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891
[TBL] [Abstract][Full Text] [Related]
7. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
Galici R; Echemendia NG; Rodriguez AL; Conn PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
[TBL] [Abstract][Full Text] [Related]
8. The role of NMDA receptors in regulating group II metabotropic glutamate receptor-mediated long-term depression in rat medial prefrontal cortex.
Huang CC; Hsu KS
Neuropharmacology; 2008 Jun; 54(7):1071-8. PubMed ID: 18378263
[TBL] [Abstract][Full Text] [Related]
9. Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.
Kopec K; Flood DG; Gasior M; McKenna BA; Zuvich E; Schreiber J; Salvino JM; Durkin JT; Ator MA; Marino MJ
Biochem Pharmacol; 2010 Nov; 80(9):1407-17. PubMed ID: 20637735
[TBL] [Abstract][Full Text] [Related]
10. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
[TBL] [Abstract][Full Text] [Related]
11. Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in mice.
Takatsu Y; Fujita Y; Tsukamoto T; Slusher BS; Hashimoto K
Brain Res; 2011 Jan; 1371():82-6. PubMed ID: 21093418
[TBL] [Abstract][Full Text] [Related]
12. Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.
Profaci CP; Krolikowski KA; Olszewski RT; Neale JH
Psychopharmacology (Berl); 2011 Jul; 216(2):235-43. PubMed ID: 21327758
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological evidence of functional inhibitory metabotrophic glutamate receptors on mouse arousal-related cholinergic laterodorsal tegmental neurons.
Kohlmeier KA; Christensen MH; Kristensen MP; Kristiansen U
Neuropharmacology; 2013 Mar; 66():99-113. PubMed ID: 22381584
[TBL] [Abstract][Full Text] [Related]
14. DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2/3 receptor stimulation.
Wischhof L; Aho HE; Koch M
Pharmacol Biochem Behav; 2012 Jul; 102(1):6-12. PubMed ID: 22469865
[TBL] [Abstract][Full Text] [Related]
15. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.
Di Liberto V; Bonomo A; Frinchi M; Belluardo N; Mudò G
Neuroscience; 2010 Feb; 165(3):863-73. PubMed ID: 19909793
[TBL] [Abstract][Full Text] [Related]
16. Disruption of prepulse inhibition in mice lacking mGluR1.
Brody SA; Conquet F; Geyer MA
Eur J Neurosci; 2003 Dec; 18(12):3361-6. PubMed ID: 14686909
[TBL] [Abstract][Full Text] [Related]
17. Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate (NAAG).
Romei C; Raiteri M; Raiteri L
Neuropharmacology; 2013 Mar; 66():311-6. PubMed ID: 22659408
[TBL] [Abstract][Full Text] [Related]
18. Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment.
Kjaerby C; Bundgaard C; Fejgin K; Kristiansen U; Dalby NO
Neuropharmacology; 2013 Sep; 72():157-68. PubMed ID: 23643744
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological stimulation of group ii metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys.
Adewale AS; Platt DM; Spealman RD
J Pharmacol Exp Ther; 2006 Aug; 318(2):922-31. PubMed ID: 16675638
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
